Literature DB >> 17379666

Mania-like behavior induced by disruption of CLOCK.

Kole Roybal1, David Theobold, Ami Graham, Jennifer A DiNieri, Scott J Russo, Vaishnav Krishnan, Sumana Chakravarty, Joseph Peevey, Nathan Oehrlein, Shari Birnbaum, Martha H Vitaterna, Paul Orsulak, Joseph S Takahashi, Eric J Nestler, William A Carlezon, Colleen A McClung.   

Abstract

Circadian rhythms and the genes that make up the molecular clock have long been implicated in bipolar disorder. Genetic evidence in bipolar patients suggests that the central transcriptional activator of molecular rhythms, CLOCK, may be particularly important. However, the exact role of this gene in the development of this disorder remains unclear. Here we show that mice carrying a mutation in the Clock gene display an overall behavioral profile that is strikingly similar to human mania, including hyperactivity, decreased sleep, lowered depression-like behavior, lower anxiety, and an increase in the reward value for cocaine, sucrose, and medial forebrain bundle stimulation. Chronic administration of the mood stabilizer lithium returns many of these behavioral responses to wild-type levels. In addition, the Clock mutant mice have an increase in dopaminergic activity in the ventral tegmental area, and their behavioral abnormalities are rescued by expressing a functional CLOCK protein via viral-mediated gene transfer specifically in the ventral tegmental area. These findings establish the Clock mutant mice as a previously unrecognized model of human mania and reveal an important role for CLOCK in the dopaminergic system in regulating behavior and mood.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17379666      PMCID: PMC1851061          DOI: 10.1073/pnas.0609625104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Anxiolytic-like effect of paeonol in mice.

Authors:  Xiao Juan Mi; Si Wei Chen; Wen Juan Wang; Rui Wang; Yi Jing Zhang; Wei Jing Li; Yu Lei Li
Journal:  Pharmacol Biochem Behav       Date:  2005-07       Impact factor: 3.533

2.  Clock genes: influencing and being influenced by psychoactive drugs.

Authors:  Hari Manev; Tolga Uz
Journal:  Trends Pharmacol Sci       Date:  2006-03-02       Impact factor: 14.819

3.  Behavioral effects of short-term administration of lithium and valproic acid in rats.

Authors:  Hilarie C Tomasiewicz; Stephen D Mague; Bruce M Cohen; William A Carlezon
Journal:  Brain Res       Date:  2006-05-09       Impact factor: 3.252

Review 4.  Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders.

Authors:  D B Boivin
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

5.  Lithium's effect in forced-swim test is blood level dependent but not dependent on weight loss.

Authors:  Yuly Bersudsky; Alona Shaldubina; R H Belmaker
Journal:  Behav Pharmacol       Date:  2007-02       Impact factor: 2.293

6.  Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia.

Authors:  H A Mansour; J Wood; T Logue; K V Chowdari; M Dayal; D J Kupfer; T H Monk; B Devlin; V L Nimgaonkar
Journal:  Genes Brain Behav       Date:  2006-03       Impact factor: 3.449

7.  A role for glycogen synthase kinase-3beta in the mammalian circadian clock.

Authors:  Chisato Iitaka; Koyomi Miyazaki; Toshihiro Akaike; Norio Ishida
Journal:  J Biol Chem       Date:  2005-06-22       Impact factor: 5.157

8.  Ser-557-phosphorylated mCRY2 is degraded upon synergistic phosphorylation by glycogen synthase kinase-3 beta.

Authors:  Yuko Harada; Mihoko Sakai; Nobuhiro Kurabayashi; Tsuyoshi Hirota; Yoshitaka Fukada
Journal:  J Biol Chem       Date:  2005-06-24       Impact factor: 5.157

9.  Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder.

Authors:  Caroline M Nievergelt; Daniel F Kripke; Thomas B Barrett; Elyssa Burg; Ronald A Remick; A Dessa Sadovnick; Susan L McElroy; Paul E Keck; Nicholas J Schork; John R Kelsoe
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-04-05       Impact factor: 3.568

Review 10.  Molecular components of the mammalian circadian clock.

Authors:  Caroline H Ko; Joseph S Takahashi
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

View more
  307 in total

1.  Analysis of target genes regulated by chronic electroconvulsive therapy reveals role for Fzd6 in depression.

Authors:  Bhavya Voleti; Keith Q Tanis; Samuel S Newton; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2011-09-19       Impact factor: 13.382

Review 2.  The behavioral activation system and mania.

Authors:  Sheri L Johnson; Michael D Edge; M Kathleen Holmes; Charles S Carver
Journal:  Annu Rev Clin Psychol       Date:  2011-11-07       Impact factor: 18.561

3.  Psychiatry's age of enlightenment: optogenetics and the discovery of novel targets for the treatment of psychiatric disorders.

Authors:  Michelle M Sidor
Journal:  J Psychiatry Neurosci       Date:  2012-01       Impact factor: 6.186

Review 4.  Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders.

Authors:  Ming-Hu Han; Allyson K Friedman
Journal:  Neuropharmacology       Date:  2011-09-17       Impact factor: 5.250

5.  A wheel of time: the circadian clock, nuclear receptors, and physiology.

Authors:  Xiaoyong Yang
Journal:  Genes Dev       Date:  2010-04-15       Impact factor: 11.361

Review 6.  Circadian rhythms and mood regulation: insights from pre-clinical models.

Authors:  Colleen A McClung
Journal:  Eur Neuropsychopharmacol       Date:  2011-08-11       Impact factor: 4.600

7.  Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans.

Authors:  David T Dao; Pamela Belmonte Mahon; Xiang Cai; Colleen E Kovacsics; Robert A Blackwell; Michal Arad; Jianxin Shi; Peter P Zandi; Patricio O'Donnell; James A Knowles; Myrna M Weissman; William Coryell; William A Scheftner; William B Lawson; Douglas F Levinson; Scott M Thompson; James B Potash; Todd D Gould
Journal:  Biol Psychiatry       Date:  2010-08-17       Impact factor: 13.382

8.  Dynamically Timed Stimulation of Corticolimbic Circuitry Activates a Stress-Compensatory Pathway.

Authors:  David Carlson; Lisa K David; Neil M Gallagher; Mai-Anh T Vu; Matthew Shirley; Rainbo Hultman; Joyce Wang; Caley Burrus; Colleen A McClung; Sunil Kumar; Lawrence Carin; Stephen D Mague; Kafui Dzirasa
Journal:  Biol Psychiatry       Date:  2017-06-15       Impact factor: 13.382

9.  Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior.

Authors:  Sade Spencer; Edgardo Falcon; Jaswinder Kumar; Vaishnav Krishnan; Shibani Mukherjee; Shari G Birnbaum; Colleen A McClung
Journal:  Eur J Neurosci       Date:  2012-10-08       Impact factor: 3.386

10.  Chronotype and cellular circadian rhythms predict the clinical response to lithium maintenance treatment in patients with bipolar disorder.

Authors:  Michael J McCarthy; Heather Wei; Caroline M Nievergelt; Andrea Stautland; Adam X Maihofer; David K Welsh; Paul Shilling; Martin Alda; Ney Alliey-Rodriguez; Amit Anand; Ole A Andreasson; Yokesh Balaraman; Wade H Berrettini; Holli Bertram; Kristen J Brennand; Joseph R Calabrese; Cynthia V Calkin; Ana Claasen; Clara Conroy; William H Coryell; David W Craig; Nicole D'Arcangelo; Anna Demodena; Srdjan Djurovic; Scott Feeder; Carrie Fisher; Nicole Frazier; Mark A Frye; Fred H Gage; Keming Gao; Julie Garnham; Elliot S Gershon; Kara Glazer; Fernando Goes; Toyomi Goto; Gloria Harrington; Petter Jakobsen; Masoud Kamali; Elizabeth Karberg; Marisa Kelly; Susan G Leckband; Falk Lohoff; Melvin G McInnis; Francis Mondimore; Gunnar Morken; John I Nurnberger; Sarah Obral; Ketil J Oedegaard; Abigail Ortiz; Megan Ritchey; Kelly Ryan; Martha Schinagle; Helle Schoeyen; Candice Schwebel; Martha Shaw; Tatyana Shekhtman; Claire Slaney; Emma Stapp; Szabolcs Szelinger; Bruce Tarwater; Peter P Zandi; John R Kelsoe
Journal:  Neuropsychopharmacology       Date:  2018-11-16       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.